BNS up +0.95% percent right now. $BNS High is at 60.59 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
BNS up +0.95% percent right now. $BNS High is at 60.59 and the Low 59.97 with current volume of 271,681.

Recent News posted below.

BNS Bank of Nova Scotia Recent Headline News

Canadian Imperial Bank Of Commerce: Next Stop $110?
Livio Filice - at Seeking Alpha - Thu Nov 06, 1:35PM CST

TD: 49.86 (+0.37), JPM: 61.35 (-0.58), RY: 72.23 (+0.60), CM: 91.61 (+0.58), BNS: 60.43 (+0.53)

Dividend Income Update - October 2014
Dividend Mantra - Seeking Alpha - Wed Nov 05, 6:22PM CST
Another month has passed by, and it's time for me to post an article on my favorite subject: dividend income. The reason why I love to post articles on dividend income is because it's pure numbers. It's hard to argue the success of long-term dividend...
KO: 42.51 (+0.12), GE: 26.32 (-0.15), MDT: 68.93 (+0.22), RTN: 103.56 (+0.04), SYY: 38.47 (-0.18), MO: 49.30 (-0.57), BNS: 60.43 (+0.53), ITW: 92.92 (-0.15), PM: 88.01 (-0.41), BAX: 70.70 (+0.07), ARCP: 8.70 (+0.20)

Downgrade Alert for Bank of Nova Scotia (BNS)
Comtex SmarTrend(R) - Wed Nov 05, 7:05AM CST
Bank of Nova Scotia (NYSE:BNS) was downgraded from Outperformer to Sector Performer at CIBC today. The stock closed yesterday at $58.88 on volume of 1.5 million shares, above average daily volume of 740,000. Bank of Nova Scotia share prices have moved between a 52-week high of $68.71 and a 52-week low of $53.94 and closed yesterday at 9% above that low price at $58.88 per share. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.7%.
BNS: 60.43 (+0.53)

Scotiabank to cut jobs, take charge
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 2:36PM CST

BNS: 60.43 (+0.53)

Scotiabank Provides Information on Notable Charges Impacting Fourth Quarter 2014 Results
Marketwired - Tue Nov 04, 3:00AM CST
Scotiabank (TSX: BNS) (NYSE: BNS) today announced that it expects to record certain charges in its fiscal 2014 fourth quarter earnings, aggregating to a total of approximately $451 million pre-tax, or $341 million after tax. Diluted earnings per share are expected to be impacted by approximately $0.28. These items will also impact the Bank's Common Equity Tier 1 capital ratio by approximately 10 basis points. The charges fall into two broad categories: (1) changes in estimates and additional credit provisions; and (2) restructuring charges.
BNS.TO: 68.47 (+0.27), BNS: 60.43 (+0.53)

November Stock Considerations
Divhut - at Seeking Alpha - Mon Nov 03, 9:02PM CST
As the month of November begins, I look at my portfolio holdings and wonder where I’d like to deploy my cash. This is the first month where I don’t really have a clear conviction of where I’d like to invest as the market has reached...
BMO: 71.75 (+0.27), BDX: 128.69 (+0.39), BCR: 164.03 (+0.16), TD: 49.86 (+0.37), RY: 72.23 (+0.60), VFC: 70.53 (-0.09), GWW: 246.37 (-2.40), UL: 40.72 (+0.39), CM: 91.61 (+0.58), BMS: 39.13 (-0.17), BNS: 60.43 (+0.53)

Stock Picks For This Year
Dividend Venture - at Seeking Alpha - Mon Nov 03, 8:36PM CST
It's probably too early to start celebrating Christmas unless you are a city mall already trying to lure shoppers into spending that extra Christmas money months before the season starts. I usually write a post for each of my purchases, but this was...
JNJ: 108.85 (+0.03), MMM: 157.04 (-0.62), UTX: 108.31 (-0.69), UL: 40.72 (+0.39), BNS: 60.43 (+0.53), VTR: 68.56 (-0.05)

Barclays PLC (BCS) Jumps: Stock Gains 7.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:04AM CST
Barclays PLC (BCS) was a big mover last session, as the company saw its shares rise over 7% on the day.
BCS: 14.94 (+0.07), RBS: 12.04 (+0.06), ITUB: 14.08 (-0.03), BNS: 60.43 (+0.53)

Dividend Champions For November 2014
David Fish - at Seeking Alpha - Sun Nov 02, 3:36AM CST

BTI: 115.58 (+0.92), THO: 55.03 (+0.14), BOKF: 68.25 (-0.39), HBAN: 10.11 (-0.02), NMM: 13.47 (-0.17), KKR: 21.69 (-0.15), BNS: 60.43 (+0.53), SNH: 22.34 (unch), DEO: 118.61 (+0.45), STAG: 24.14 (-0.15), SBUX: 77.80 (+0.15), AEP: 57.84 (-0.54), KIM: 24.82 (-0.12), EGN: 68.75 (+0.14), SHPG: 202.08 (+1.10), BBSI: 23.19 (-1.09), AMAT: 22.55 (-0.08), SIX: 40.30 (+0.37), NSH: 36.90 (+0.24), RGR: 37.09 (-0.19), DBD: 36.13 (+0.11), NEU: 390.22 (+0.25), LNC: 56.30 (+0.21), DRI: 55.78 (+1.47), POL: 37.62 (+0.24), PLL: 93.87 (-0.40), RY: 72.23 (+0.60), WCN: 50.35 (+0.01), MAC: 69.43 (-0.12), NAUH: 3.04 (+0.02), ENVE: 19.28 (+0.57), AMTD: 35.30 (+0.24)

The Canadian Foundation for Economic Education and Scotiabank Introduce New Financial Education Program for Young Entrepreneurs
Marketwire Canada - Wed Oct 29, 11:00AM CDT
The Canadian Foundation for Economic Education (CFEE), in partnership with Scotiabank, today launched its new program "Entrepreneurship: The Spirit of Adventure."
BNS.TO: 68.47 (+0.27), BNS: 60.43 (+0.53)

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
ACW: 4.77 (-0.08), ADHD: 3.62 (-0.05), FCCY: 10.57 (-0.01), BNS: 60.43 (+0.53), ARRY: 3.85 (+0.01)

Bank Of Nova Scotia Dividend Stock Analysis
Roadmap2Retire - at Seeking Alpha - Mon Oct 27, 3:36PM CDT

BNS: 60.43 (+0.53)

Shares of BNS Down 8.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Oct 23, 11:11AM CDT
SmarTrend identified a Downtrend for Bank of Nova Scotia (NYSE:BNS) on August 7th, 2014 at $66.20. In approximately 3 months, Bank of Nova Scotia has returned 8.92% as of today's recent price of $60.29.
BNS: 60.43 (+0.53)

Scotiabank Named to World's Best Multinational Workplaces List
Marketwire Canada - Thu Oct 23, 10:56AM CDT
Scotiabank today became the first Canadian-based company to be named to the "World's Best Multinational Workplaces" list. The 2014 list of 25 companies was announced in an online forum hosted by the Great Place to WorkA® Institute at 7:00am (PDT) this morning.
BNS.TO: 68.47 (+0.27), BNS: 60.43 (+0.53)

Scotiabank sitting on too-large of a capital cushion
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:43PM CDT

BNS: 60.43 (+0.53)

Cineplex Cinemas Avalon Mall Re-Named Scotiabank Theatre St. John's
Marketwire Canada - Thu Oct 16, 7:00AM CDT
Cineplex Entertainment (TSX: CGX) and Scotiabank (TSX: BNS)(NYSE: BNS) today announced that Cineplex Cinemas Avalon Mall, one of Cineplex's flagship locations in Atlantic Canada, will be re-named Scotiabank Theatre St. John's.
BNS.TO: 68.47 (+0.27), CGX.TO: 42.46 (+0.02), BNS: 60.43 (+0.53)

Cineplex Cinemas Bayers Lake Re-Named Scotiabank Theatre Halifax
Marketwire Canada - Thu Oct 16, 7:00AM CDT
Cineplex Entertainment (TSX: CGX) and Scotiabank (TSX: BNS)(NYSE: BNS) today announced that Cineplex Cinemas Bayers Lake, one of Cineplex's flagship locations in Atlantic Canada, will be re-named Scotiabank Theatre Halifax.
BNS.TO: 68.47 (+0.27), CGX.TO: 42.46 (+0.02), BNS: 60.43 (+0.53)

A Review Of Holding Out For Better Prices On Some Dividend Growth Stocks Over The Next 2 Months
Henry Nyce - at Seeking Alpha - Tue Oct 14, 5:13PM CDT

GE: 26.32 (-0.15), FLY: 12.44 (-0.12), FCX: 28.48 (+0.46), NNN: 38.30 (-0.63), WMT: 79.03 (-0.41), SLF: 36.11 (+0.21), O: 46.92 (-0.18), BNS: 60.43 (+0.53), WM: 49.36 (-0.13), T: 35.06 (-0.06), PAYX: 47.25 (-0.25), MSEX: 22.89 (-0.01), MOCO: 16.55 (-0.31), PPL: 36.56 (-0.22), BIP: 41.09 (+0.14), PG: 89.68 (+0.23), MCY: 55.06 (-0.31), CSCO: 25.08 (-0.07), NE: 21.28 (+0.13)

SCENE and Sport Chek Announce Strategic Marketing Partnership
CNW Group - Thu Oct 09, 6:45AM CDT
Sport Chek, Cineplex and Scotiabank to attract new customers through year-round marketing campaigns and highly-attractive lifestyle and entertainment rewards
BNS.TO: 68.47 (+0.27), CGX.TO: 42.46 (+0.02), BNS: 60.43 (+0.53), CTC.TO: 220.00 (+0.25)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 116

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

Updated Category News Views 67

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....

Continue Reading
Tabañero Spices Up Holidays with $10 Gift Sets

Updated Category News Views 120

Hot Sauce, Spicy Gifting, and Bold Barbecue When holiday cheer mixes with a dash of heat, you end up with something as electrifying as Tabañero's latest offerings. This Florida-based player is nudging its way into the gift-giving scene with a lineup that's as spicy as it is thoughtful. Frankly, if you're scrambling for stocking stuffers or a memorable Secret Santa...

Continue Reading
E-Bike Demo Day Spurs New Jersey's Policy Insights

Updated Category News Views 88

Velotric Sets the Stage for E-Bike Insights The chatter over at Trenton has been electric—and I mean that literally. On October 29, Assemblywoman Tennille R. McCoy will open the gates of the New Jersey State House to host an E-Bike Demonstration and Education Day. The goal? To slap some sense into lawmakers' understanding of the buzzing e-bike market. Velotric, a major...

Continue Reading
Keeping Halloween Safe and Fun with AHN Tips

Updated Category News Views 95

Trick or Treat the Safe Way Ah, Halloween. A time when you don't just get to pretend to be someone else; you get to pile on the candy like it's a second job. But hold up! Before your pint-sized Dracula sprints into the foggy night, heed some wisdom from the folks at Allegheny Health Network. They aren't just offering another bowl of sugar-coated advice; they've got...

Continue Reading
Sol Taps Silberman: Bold New Era for Marketing Shift

Updated Category News Views 153

Bringing Media Savvy to AI Strategy Dan Silberman, the seasoned media executive from A+E Global Media, just jumped ship to helm marketing and communications at Sol, a firm peddling its ware in AI-enabled business transformation. Maybe you're scratching your head, wondering why the heck it matters. Well, as I see it, this ain't just another name change on a corporate...

Continue Reading
Uwharrie Capital's 2026 Q3 Shows Steady Growth

Updated Category News Views 79

Uwharrie Capital's Financial Dance Well, don't dust off the neon ticker tape quite yet but Uwharrie Capital Corp (OTCQX:UWHR) gave us a reason to nod approvingly over our espresso this quarter. From a scrappy hometown operation to a regional bank showing its mettle, the numbers they've laid down ain't half bad. Assets Climb a Billion-Dollar Ladder First thing that jumps...

Continue Reading
Hehe Forum Stirs Global Harmony in Taizhou, China

Updated Category News Views 70

Reflecting on Hehe Culture's Impact Seems like everyone and their neighbor are flocking to Taizhou for the annual Hehe Culture Forum. It's not your run-of-the-mill gathering; more than 220 folks from 23 different countries showed up, diving deep into the murky waters of cultural exchange, global governance, and international cooperation. Now, if you think it's just...

Continue Reading
Unity Crucial for Global South's Economic Gains

Updated Category News Views 37

Anytime you hear the 'Global South' being bandied about these days, you know someone's talking about the clout shifting in the world. In Beijing this week, they were hashing out how these nations can crank up their collective volume on the global stage. Gathering Brains in Beijing At the Global Strategic Dialogue 2026, held slap-bang in Beijing, experts and high-profile...

Continue Reading
Biopharma Rethinks Strategy Amid U.S. MFN Pricing Shift

Updated Category News Views 128

Global Pharma Grapples with U.S. MFN Pricing Sometimes, regulatory changes hit the industry like a freight train, and other times they creep in like the tide reshaping everything without much fanfare. The U.S. Most-Favored-Nation (MFN) pricing rule, spotlighted in a recent World ACCESS Consortium (WAC) white paper, might be the latter. It’s bending biopharmaceuticals'...

Continue Reading

Top 5 Most Recently Viewed Articles

Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Updated Category News Views 30

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

Continue Reading
Investigation of CNB Bank Shares: Your Rights as a Shareholder

Updated Category News Views 244

Investigation of CNB Bank Shares Inc. Transactions Recently, the M&A Class Action Firm has launched an investigation regarding CNB Bank Shares, Inc. (OTCMKTS: CNBN) due to its proposed sale to HBT Financial, Inc. This inquiry seeks to determine if the deal being offered to shareholders is fair and just. When a company is involved in such significant transactions, it...

Continue Reading
Strategies for Trading SPY and Top Tech Stocks Effectively

Updated Category News Views 162

Analyzing Market Dynamics for Effective Trading Good morning traders! As we dive into this exciting trading day, it’s crucial to understand the key dynamics that may influence the market. Key Economic Indicators Impacting Trading The ADP Employment report, coming at 8:15 AM ET, serves as an initial glimpse into private payrolls, shaping our expectations for official...

Continue Reading
aTyr Pharma Faces Legal Backlash After Drug Trial Failure

Updated Category News Views 174

aTyr Pharma's Recent Legal Struggles In a notable case in the biotech sector, aTyr Pharma, Inc. (NASDAQ: ATYR) is currently grappling with significant legal challenges following an alarming 83% decline in its stock price. This dramatic turn stems from the company's lead drug candidate's failure in a critical Phase 3 trial. Such setbacks can have profound...

Continue Reading
JFrog Ltd. (FROG) Faces Scrutiny as Investigation Unfolds

Updated Category News Views 359

Investigation of JFrog Ltd. (FROG) by Law Offices of Howard G. Smith The Law Offices of Howard G. Smith is actively investigating JFrog Ltd. (“JFrog” or the “Company”) (NASDAQ: FROG) on behalf of its investors. This investigation centers around potential violations of federal securities laws that may have affected shareholders. Recent Financial Performance and...

Continue Reading